Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: HRD018
MIFTS: 41

Hair Disease

Categories: Rare diseases, Skin diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Hair Disease

About this section

MalaCards integrated aliases for Hair Disease:

Name: Hair Disease 12 15
Hair Diseases 43 71
Hair Disorder 54
Hair Problems 42
Hair Anomaly 58

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Skin diseases
See all MalaCards categories (disease lists)
Orphanet: 58  
Rare skin diseases


External Ids:

Disease Ontology 12 DOID:421
MeSH 43 D006201
NCIt 49 C34656
UMLS via Orphanet 72 C0265991
Orphanet 58 ORPHA79363
UMLS 71 C0018500
Sources

Summaries for Hair Disease

About this section
MedlinePlus : 42 The average person has 5 million hairs. Hair grows all over your body except on your lips, palms, and the soles of your feet. It takes about a month for healthy hair to grow half an inch. Most hairs grow for up to six years and then fall out. New hairs grow in their place. Hair helps keep you warm. It also protects your eyes, ears and nose from small particles in the air. Common problem with the hair and scalp include hair loss, infections, and flaking.

MalaCards based summary : Hair Disease, also known as hair diseases, is related to monilethrix and familial woolly hair syndrome, and has symptoms including pruritus and exanthema. An important gene associated with Hair Disease is KRT86 (Keratin 86), and among its related pathways/superpathways is Innate Lymphoid Cell Differentiation Pathways. The drugs Minoxidil and Antihypertensive Agents have been mentioned in the context of this disorder. Affiliated tissues include hair, skin and eye, and related phenotype is integument.

Disease Ontology : 12 An integumentary system disease that is located in hair.

Wikipedia : 74 Hair diseases are disorders primarily associated with the follicles of the... more...

Sources

Related Diseases for Hair Disease

About this section

Diseases in the Hair Disease family:

Hair-an Syndrome

Diseases related to Hair Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 453, show less)
# Related Disease Score Top Affiliating Genes
1 monilethrix 33.0 LPAR6 LIPH KRT86 KRT81 DSG4
2 familial woolly hair syndrome 32.9 LPAR6 LIPH
3 hypotrichosis 7 32.5 LPAR6 LIPH DSG4
4 hypotrichosis 31.9 PRDM10 MBTPS2 LPP LPAR6 LIPH KRT86
5 alopecia 31.3 MBTPS2 KRT86 KRT81 DSP
6 androgenic alopecia 31.1 LPP KRT86 ANTXR2
7 vitiligo-associated multiple autoimmune disease susceptibility 1 30.7 ICOSLG CD8A CD4 CCR6
8 keratosis 30.7 MBTPS2 DSP DSG4
9 systemic scleroderma 30.7 ICOSLG H2AC18 CD8A CD4 CCR6
10 cerebral degeneration 30.7 PRDM10 H2AC18 ERCC6 ALB
11 hypotrichosis, congenital, with juvenile macular dystrophy 30.6 MBTPS2 LPAR6 LIPH DSG4
12 immunoglobulin alpha deficiency 30.5 ICOSLG CD8A CD4 CCR6
13 trichothiodystrophy 1, photosensitive 30.5 H2AC18 ERCC6 ERCC3
14 dermatitis, atopic 30.5 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
15 telangiectasis 30.5 H2AC18 ERCC6 CCR6
16 severe cutaneous adverse reaction 30.5 CD8A CD4 ALB
17 cellulitis 30.4 ICOSLG DSP DSG4 CD8A CD4 CCR6
18 x-linked recessive disease 30.4 PRDM10 ICOSLG H2AC18 ERCC6 CD8A CD4
19 telogen effluvium 30.4 LPP ANTXR2
20 connective tissue disease 30.2 KDM4C ICOSLG H2AC18 ERCC6 CD8A CD4
21 skin disease 30.1 ICOSLG H2AC18 ERCC6 DSP DSG4 CD8A
22 genetic hair anomaly 12.2
23 menkes disease 11.9
24 ringed hair 11.3
25 hypertrichosis 11.2
26 pseudofolliculitis barbae 11.2
27 noonan syndrome-like disorder with loose anagen hair 1 11.1
28 blepharocheilodontic syndrome 1 11.0
29 hairy elbows 11.0
30 blepharocheilodontic syndrome 2 11.0
31 clouston syndrome 10.9
32 riedel's fibrosing thyroiditis 10.8 CD4 ALB
33 hereditary lymphedema 10.8 PRDM10 KDM4C H2AC18
34 autoimmune vasculitis 10.8 H2AC18 CD4 CCR6
35 anti-basement membrane glomerulonephritis 10.8 CD4 CCR6 ALB
36 cork-handlers' disease 10.8 CD8A CD4 ALB
37 spongiotic dermatitis 10.8 CD8A CD4 CCR6
38 t-cell immunodeficiency, congenital alopecia, and nail dystrophy 10.8 LPAR6 LIPH DSG4
39 angular cheilitis 10.8 MBTPS2 CD4 ALB
40 esophageal candidiasis 10.8 CD8A CD4 CCR6
41 pneumonic tularemia 10.8 CD8A CD4 CCR6
42 hypotrichosis 6 10.8 LPAR6 LIPH DSG4
43 blastomycosis 10.8 CD8A CD4 CCR6
44 hypotrichosis 13 10.8 LPAR6 LIPH DSG4
45 mikulicz disease 10.8 ICOSLG CD4 CCR6
46 pneumonic plague 10.8 LPP CD8A CD4
47 granulomatous hepatitis 10.8 CD8A CD4 ALB
48 mucocutaneous leishmaniasis 10.8 H2AC18 CD8A CD4
49 hypotrichosis 8 10.8 LPAR6 LIPH DSG4
50 cecal disease 10.8 H2AC18 CCR6 ALB
51 hypotrichosis simplex 10.8 LPAR6 LIPH DSG4
52 central nervous system vasculitis 10.8 CD8A CD4 CCR6
53 cranial nerve palsy 10.8 CD4 ANTXR2 ALB
54 mucormycosis 10.8 CSF3 CD4 CCR6
55 orchitis 10.8 H2AC18 CD8A CD4
56 t-cell adult acute lymphocytic leukemia 10.8 CD8A CD4 CCR6
57 syphilitic meningitis 10.8 CD8A CD4
58 folliculitis 10.8 MBTPS2 LPP CD4 CCR6
59 anus cancer 10.8 H2AC18 CD8A CD4
60 duodenitis 10.8 CD8A CD4 ALB
61 primary systemic mycosis 10.8 CD8A CD4 CCR6
62 corticosteroid allergy 10.8 CD8A CD4 ALB
63 chronic conjunctivitis 10.8 ICOSLG CD4 CCR6
64 atrichia with papular lesions 10.8 MBTPS2 LIPH KDM4C DSG4
65 pachyonychia congenita 1 10.8 MBTPS2 KRT86 DSP
66 anogenital venereal wart 10.8 H2AC18 CD8A CD4
67 keratoconjunctivitis sicca 10.8 CD4 CCR6 ALB
68 taeniasis 10.8 CD8A CD4 ALB
69 follicular mucinosis 10.8 MBTPS2 LPP CD8A CD4
70 nut allergy 10.8 ICOSLG CD4 CCR6
71 autoimmune disease of skin and connective tissue 10.8 ICOSLG DSP CD4 CCR6
72 goodpasture syndrome 10.8 H2AC18 CD4 ALB
73 acute myocarditis 10.8 H2AC18 CD8A CD4
74 herpangina 10.8 H2AC18 CD8A CD4 CCR6
75 hantavirus hemorrhagic fever with renal syndrome 10.8 CD8A CD4 ALB
76 xeroderma pigmentosum group e 10.8 H2AC18 ERCC6 ERCC3
77 ventilation pneumonitis 10.8 CD8A CD4
78 vaginal disease 10.8 H2AC18 CD8A CD4 CCR6
79 multidrug-resistant tuberculosis 10.8 CD4 ANTXR2 ALB
80 pemphigus vulgaris, familial 10.8 DSP DSG4 CCR6
81 streptococcus pneumonia 10.8 H2AC18 CD8A CD4
82 plasma protein metabolism disease 10.8 CD4 CCR6 ALB
83 blepharitis 10.7 MBTPS2 CD8A CD4 CCR6
84 histoplasmosis 10.7 CD8A CD4 CCR6
85 igg4-related disease 10.7 ICOSLG CD4 CCR6
86 t cell deficiency 10.7 CD8A CD4 CCR6
87 autoimmune disease of peripheral nervous system 10.7 ICOSLG CD4 ALB
88 acute cystitis 10.7 H2AC18 CD4 CCR6 ALB
89 anus disease 10.7 H2AC18 CD8A CD4 CCR6
90 hemorrhagic cystitis 10.7 CSF3 CD8A CD4
91 giardiasis 10.7 CD8A CD4 ALB
92 genital herpes 10.7 CD8A CD4 CCR6
93 xeroderma pigmentosum, complementation group c 10.7 H2AC18 ERCC6 ERCC3
94 brachydactyly, type c 10.7 CD8A CD4 CCR6
95 diffuse infiltrative lymphocytosis syndrome 10.7 CD8A CD4
96 drug-induced lupus erythematosus 10.7 PRDM10 H2AC18 ALB
97 bronchopneumonia 10.7 CD8A CD4 ALB
98 autoimmune lymphoproliferative syndrome, type iia 10.7 CD8A CD4
99 cryptococcosis 10.7 CD8A CD4 CCR6
100 immunodeficiency with hyper-igm, type 3 10.7 ICOSLG CD8A CD4
101 panuveitis 10.7 CD8A CD4 CCR6
102 xeroderma pigmentosum, complementation group g 10.7 H2AC18 ERCC6 ERCC3
103 acute proliferative glomerulonephritis 10.7 ICOSLG CD4 CCR6 ALB
104 xeroderma pigmentosum, complementation group b 10.7 H2AC18 ERCC6 ERCC3
105 capillary disease 10.7 CSF3 CD8A ALB
106 colonic benign neoplasm 10.7 KDM4C H2AC18 CCR6
107 middle ear disease 10.7 CD8A CD4 CCR6 ALB
108 autoimmune disease of cardiovascular system 10.7 ICOSLG CD8A CD4 CCR6
109 nail disease 10.7 CD8A CD4 CCR6
110 intestinal benign neoplasm 10.7 KDM4C H2AC18 ERCC6 CCR6
111 hereditary lymphedema i 10.7 PRDM10 KDM4C H2AC18 CD4
112 facial paralysis 10.7 CD8A CD4 ANTXR2 ALB
113 facial nerve disease 10.7 CD8A CD4 ANTXR2 ALB
114 actinomycosis 10.7 PRDM10 H2AC18 CD4 ALB
115 dacryoadenitis 10.7 ICOSLG CD8A CD4 CCR6
116 autoimmune glomerulonephritis 10.7 ICOSLG CD8A CD4 CCR6
117 adult acute lymphocytic leukemia 10.7 CSF3 CD8A CD4 CCR6
118 syphilis 10.7 CD8A CD4 CCR6 ALB
119 autoimmune disease of eyes, ear, nose and throat 10.7 ICOSLG CD8A CD4 CCR6
120 meningoencephalitis 10.7 CD8A CD4 CCR6 ALB
121 immune-complex glomerulonephritis 10.7 ICOSLG H2AC18 CD4 ALB
122 thrombocytopenia due to platelet alloimmunization 10.7 ICOSLG CD8A CD4 CCR6
123 childhood type dermatomyositis 10.7 ICOSLG CD8A CD4 CCR6
124 primary thrombocytopenia 10.7 ICOSLG CD8A CD4 CCR6
125 xeroderma pigmentosum, complementation group d 10.7 H2AC18 ERCC6 ERCC3
126 dysentery 10.7 PRDM10 CD4 CCR6 ALB
127 sialadenitis 10.7 ICOSLG CD8A CD4 CCR6
128 autoimmune disease of blood 10.7 ICOSLG CD8A CD4 CCR6
129 cryptosporidiosis 10.7 CSF3 CD8A CD4
130 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.7 ICOSLG CD8A CD4 CCR6
131 uv-sensitive syndrome 10.7 H2AC18 ERCC6 ERCC3
132 hypersplenism 10.7 CSF3 CD4 ALB
133 salmonellosis 10.7 CD8A CD4 CCR6 ALB
134 lacrimal apparatus disease 10.7 ICOSLG CD8A CD4 CCR6
135 hepatic vascular disease 10.7 CSF3 CCR6 ALB
136 bone resorption disease 10.7 H2AC18 ERCC6 CCR6 ALB
137 mast cell neoplasm 10.7 ICOSLG H2AC18 CD8A CD4
138 alcohol use disorder 10.7 KDM4C H2AC18 CCR6 ALB
139 viral encephalitis 10.7 CD8A CD4 CCR6
140 miliary tuberculosis 10.7 CSF3 CD8A CD4 ALB
141 oral candidiasis 10.7 CD8A CD4 CCR6
142 leprosy 3 10.7 CD8A CD4 CCR6 ALB
143 progressive multifocal leukoencephalopathy 10.7 ICOSLG CD8A CD4 CCR6
144 bone remodeling disease 10.7 H2AC18 ERCC6 CCR6 ALB
145 pericardium disease 10.7 CD8A CD4 ALB
146 common cold 10.7 ICOSLG CD4 CCR6 ALB
147 chromosome 14q11-q22 deletion syndrome 10.7 CD8A CD4
148 paranasal sinus disease 10.7 ICOSLG CD8A CD4 CCR6
149 anemia, autoimmune hemolytic 10.7 ICOSLG CD8A CD4
150 diabetes mellitus, insulin-dependent, 23 10.7 CD8A CD4
151 invasive aspergillosis 10.7 CSF3 CD4 CCR6
152 b cell deficiency 10.7 ICOSLG CD8A CD4 CCR6
153 respiratory allergy 10.7 ICOSLG CD8A CD4 CCR6
154 retinitis pigmentosa 18 10.7 PRDM10 H2AC18 ALB
155 acute t cell leukemia 10.7 LPP KDM4C CD8A CD4
156 pfeiffer syndrome 10.7 H2AC18 CD8A CD4 CCR6
157 endocardium disease 10.7 PRDM10 CD4 ALB
158 bird fancier's lung 10.7 CD8A CD4
159 blood protein disease 10.7 ICOSLG H2AC18 ALB
160 splenic disease 10.7 H2AC18 CD8A CD4 CCR6 ALB
161 early yaws 10.7 CD8A CD4
162 rectal disease 10.7 H2AC18 CD8A CD4 CCR6 ALB
163 plague 10.7 PRDM10 CD8A CD4 ALB
164 capillary leak syndrome 10.7 ICOSLG CSF3 CD8A ALB
165 bullous skin disease 10.7 ICOSLG DSP DSG4 CD4 CCR6
166 palmoplantar keratosis 10.7 MBTPS2 DSP DSG4
167 pelizaeus-merzbacher disease 10.7 PRDM10 H2AC18 ERCC6 ALB
168 plasma cell neoplasm 10.7 ICOSLG CD8A ALB
169 iga glomerulonephritis 10.7 ICOSLG CCR6 ALB
170 pleural disease 10.7 H2AC18 CD8A CD4 CCR6 ALB
171 ocular cancer 10.7 KDM4C H2AC18 CD8A CD4
172 thrombocytopenic purpura, autoimmune 10.7 ICOSLG CD4 CCR6
173 keratitis, hereditary 10.7 CD8A CD4 CCR6
174 cerebellopontine angle tumor 10.7 KRT86 ANTXR2
175 bare lymphocyte syndrome, type ii 10.7 H2AC18 CD8A CD4
176 chronic mucocutaneous candidiasis 10.7 CSF3 CD8A CD4 CCR6
177 listeriosis 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
178 chronic graft versus host disease 10.7 CD4 ALB
179 lichen disease 10.7 LPP ICOSLG CD8A CD4 CCR6
180 thymus gland disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
181 autoimmune disease of endocrine system 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
182 thymus cancer 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
183 muscle tissue disease 10.7 ICOSLG H2AC18 ERCC6 CCR6
184 combined t cell and b cell immunodeficiency 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
185 salivary gland disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
186 extrinsic cardiomyopathy 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
187 pneumocystosis 10.7 CSF3 CD8A CD4 CCR6 ALB
188 biliary tract disease 10.7 KDM4C ICOSLG H2AC18 CCR6 ALB
189 uveal disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
190 collagen disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
191 thyroid gland disease 10.7 ICOSLG H2AC18 CCR6 ALB
192 dengue disease 10.7 ICOSLG H2AC18 CD8A CCR6 ALB
193 epidermodysplasia verruciformis 1 10.7 CD8A CD4 CCR6
194 teeth hard tissue disease 10.7 PRDM10 H2AC18 ERCC6
195 esophageal disease 10.7 KDM4C ICOSLG H2AC18 CCR6 ALB
196 omenn syndrome 10.7 ICOSLG H2AC18 CD8A CD4
197 temporal arteritis 10.7 CD8A CD4 CCR6
198 chickenpox 10.7 ICOSLG CD8A CD4 CCR6 ALB
199 overnutrition 10.7 KDM4C ICOSLG H2AC18 CCR6 ALB
200 lymphoma, hodgkin, classic 10.7 KDM4C ICOSLG CSF3 CCR6
201 conjunctival disease 10.7 ICOSLG CD8A CD4 CCR6 ALB
202 herpes zoster 10.7 ICOSLG CD8A CD4
203 nasal cavity disease 10.7 ICOSLG CD8A CD4 CCR6 ALB
204 contractures, pterygia, and variable skeletal fusions syndrome 1a 10.7 PRDM10 KDM4C H2AC18 ERCC6 CCR6
205 cervix disease 10.7 ICOSLG H2AC18 CD4 CCR6
206 lymph node disease 10.7 ICOSLG CD8A CD4 CCR6 ALB
207 nose disease 10.7 ICOSLG CD8A CD4 CCR6 ALB
208 pancreas disease 10.7 KDM4C ICOSLG H2AC18 CCR6 ALB
209 autonomic nervous system neoplasm 10.7 PRDM10 KDM4C ICOSLG H2AC18 CCR6
210 yellow nail syndrome 10.7 CCR6 ALB
211 parapsoriasis 10.7 CD8A CD4
212 peripheral nervous system neoplasm 10.7 PRDM10 KDM4C ICOSLG H2AC18 CCR6
213 acquired metabolic disease 10.7 ICOSLG H2AC18 CD4 CCR6 ALB
214 human immunodeficiency virus infectious disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
215 nutritional deficiency disease 10.7 H2AC18 CCR6 ALB
216 bladder disease 10.7 KDM4C ICOSLG H2AC18 ERCC6 CCR6
217 demyelinating disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
218 sarcoidosis 1 10.7 ICOSLG CD8A CD4 CCR6
219 mycobacterium tuberculosis 1 10.7 ICOSLG H2AC18 CD8A CD4 CCR6
220 sphingolipidosis 10.7 PRDM10 H2AC18 ALB
221 cholangitis, primary sclerosing 10.7 ICOSLG CD8A CD4 CCR6 ALB
222 meningovascular neurosyphilis 10.7 CD4 ALB
223 norwegian scabies 10.7 CD8A CD4
224 colonic disease 10.7 KDM4C ICOSLG H2AC18 ERCC6 CCR6
225 specific developmental disorder 10.7 PRDM10 KDM4C H2AC18 ERCC6 ALB
226 mastitis 10.7 H2AC18 CCR6 ALB
227 type 1 diabetes mellitus 8 10.7 LPP CCR6
228 gonadal disease 10.7 KDM4C ICOSLG H2AC18 ERCC6 CCR6
229 suppurative lymphadenitis 10.7 CD4 CCR6
230 optic nerve disease 10.7 ICOSLG ERCC6 CD4 CCR6 ALB
231 pervasive developmental disorder 10.7 PRDM10 KDM4C H2AC18 ERCC6 CCR6
232 lymphadenitis 10.7 ICOSLG CD4 CCR6
233 respiratory system cancer 10.7 KDM4C ICOSLG H2AC18 ERCC6 CCR6
234 arteries, anomalies of 10.7 ICOSLG H2AC18 CCR6 ALB
235 lens disease 10.7 H2AC18 ERCC6 ALB
236 bile duct adenocarcinoma 10.7 KDM4C H2AC18 ALB
237 autosomal recessive disease 10.7 H2AC18 ERCC6 ERCC3 CCR6
238 thoracic cancer 10.7 KDM4C ICOSLG H2AC18 ERCC6 CCR6
239 reproductive system disease 10.7 KDM4C ICOSLG H2AC18 ERCC6 CCR6
240 autoimmune lymphoproliferative syndrome 10.7 ICOSLG H2AC18 CD8A CD4
241 behcet syndrome 10.7 ICOSLG CD8A CD4 CCR6 ALB
242 mouth disease 10.7 ICOSLG H2AC18 ERCC6 CCR6
243 bile duct disease 10.7 KDM4C ICOSLG H2AC18 CD4 CCR6 ALB
244 allergic hypersensitivity disease 10.7 ICOSLG H2AC18 CD4 CCR6
245 mature b-cell neoplasm 10.7 KDM4C ICOSLG H2AC18 CD8A CD4 CCR6
246 cell type cancer 10.7 KDM4C ICOSLG H2AC18 ERCC6 CCR6
247 gastrointestinal system disease 10.7 KDM4C ICOSLG H2AC18 ERCC6 CCR6
248 pyomyositis 10.7 CSF3 CD4
249 viral infectious disease 10.7 ICOSLG H2AC18 CD4 CCR6
250 toxic encephalopathy 10.7 PRDM10 H2AC18 ALB
251 crohn's disease 10.7 ICOSLG CD4 CCR6 ALB
252 coccidiosis 10.7 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
253 autoimmune disease of urogenital tract 10.7 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
254 spinal cord disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
255 neuromuscular junction disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
256 autoimmune disease of gastrointestinal tract 10.7 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
257 hypersensitivity reaction type iv disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
258 parasitic helminthiasis infectious disease 10.7 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
259 corneal disease 10.7 PRDM10 H2AC18 CD8A CD4 CCR6 ALB
260 ovarian disease 10.7 PRDM10 H2AC18 CD8A CD4 ALB
261 bacterial infectious disease 10.7 ICOSLG H2AC18 CSF3 CD8A CD4 CCR6
262 male reproductive organ cancer 10.6 KDM4C ICOSLG H2AC18 CCR6
263 autoimmune disease of musculoskeletal system 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
264 bronchial disease 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
265 autoimmune disease of central nervous system 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
266 bone inflammation disease 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
267 malignant ovarian surface epithelial-stromal neoplasm 10.6 KDM4C ICOSLG H2AC18 ERCC6 CD8A CCR6
268 ovary epithelial cancer 10.6 KDM4C ICOSLG H2AC18 ERCC6 CD8A CCR6
269 prostate disease 10.6 KDM4C ICOSLG H2AC18 CCR6
270 upper respiratory tract disease 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
271 disease of mental health 10.6 PRDM10 KDM4C H2AC18 ERCC6 CCR6 ALB
272 metal allergy 10.6 CD8A CD4
273 immune system disease 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
274 glucose metabolism disease 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
275 male reproductive system disease 10.6 KDM4C ICOSLG H2AC18 CCR6
276 chediak-higashi syndrome 10.6 PRDM10 ICOSLG H2AC18 CD8A CD4 CCR6
277 cranial nerve disease 10.6 ICOSLG ERCC6 CD4 CCR6 ANTXR2 ALB
278 variola major 10.6 CD8A CD4
279 urinary system disease 10.6 KDM4C ICOSLG H2AC18 ERCC6 CCR6 ALB
280 skin carcinoma 10.6 ICOSLG H2AC18 ERCC6 ERCC3 CSF3 CCR6
281 suppression of tumorigenicity 12 10.6 PRDM10 KDM4C H2AC18 CD8A CD4 ALB
282 respiratory system disease 10.6 KDM4C ICOSLG H2AC18 ERCC6 CD4 CCR6
283 large intestine cancer 10.6 KDM4C ICOSLG H2AC18 CCR6
284 opportunistic mycosis 10.6 ICOSLG CSF3 CD8A CD4 CCR6 ALB
285 cerebro-oculo-facio-skeletal syndrome 10.6 ERCC6 ERCC3
286 severe combined immunodeficiency 10.6 ICOSLG H2AC18 CSF3 CD4 CCR6
287 pulmonary disease, chronic obstructive 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
288 hypomyelinating leukodystrophy 10.6 PRDM10 H2AC18 ERCC6
289 congenital myasthenic syndrome 10.6 PRDM10 ERCC6 CD8A CD4 ALB
290 intrinsic cardiomyopathy 10.6 ICOSLG H2AC18 DSP
291 sezary's disease 10.6 CD8A CD4 CCR6
292 intestinal disease 10.6 KDM4C ICOSLG H2AC18 CCR6
293 tertiary syphilis 10.6 CD8A CD4
294 female reproductive system disease 10.6 ICOSLG H2AC18 ERCC6 CCR6
295 diabetes mellitus, insulin-dependent 10.6 ICOSLG H2AC18 CD8A CD4 CCR6 ALB
296 testicular disease 10.6 KDM4C H2AC18 ERCC6 CD8A CD4 CCR6
297 acute retinal necrosis syndrome 10.6 CD8A CD4
298 gastrointestinal system cancer 10.6 KDM4C ICOSLG H2AC18 CCR6
299 lymphatic system disease 10.6 KDM4C ICOSLG H2AC18 CD8A CD4 CCR6
300 nervous system disease 10.6 KDM4C ICOSLG H2AC18 ERCC6 CD4 CCR6
301 hypotrichosis 4 10.6 LPAR6 LIPH
302 nickel allergic contact dermatitis 10.6 CD8A CD4
303 celiac disease 1 10.6 LPP ICOSLG H2AC18 CD8A CD4 CCR6
304 lymphatic system cancer 10.6 KDM4C ICOSLG H2AC18 CSF3 CD8A CD4
305 connective tissue cancer 10.6 KDM4C ICOSLG H2AC18 ERCC6 CD8A CD4
306 exanthem 10.6 ICOSLG H2AC18 CSF3 CD8A CD4 CCR6
307 central nervous system disease 10.6 KDM4C ICOSLG H2AC18 ERCC6 CD4 CCR6
308 bacterial pneumonia 10.6 ICOSLG H2AC18 CSF3 CD8A CD4 CCR6
309 blood coagulation disease 10.6 ICOSLG H2AC18 CSF3 CD8A CD4 CCR6
310 aplastic anemia 10.6 H2AC18 ERCC6 CSF3 CD4 ALB
311 blood platelet disease 10.6 ICOSLG H2AC18 CSF3 CD8A CD4 CCR6
312 commensal bacterial infectious disease 10.6 PRDM10 ICOSLG H2AC18 CD8A CD4 CCR6
313 endocrine system disease 10.6 ICOSLG H2AC18 ERCC6 CCR6
314 parasitic protozoa infectious disease 10.6 PRDM10 ICOSLG H2AC18 CD8A CD4 CCR6
315 primary bacterial infectious disease 10.6 PRDM10 ICOSLG H2AC18 CD8A CD4 CCR6
316 pulmonary fibrosis, idiopathic 10.6 PRDM10 ICOSLG DSP CD8A CD4 CCR6
317 x-linked monogenic disease 10.6 PRDM10 ICOSLG H2AC18 ERCC6 CD8A CD4
318 squamous cell carcinoma, head and neck 10.6 KDM4C ICOSLG H2AC18 ERCC6 CD8A CCR6
319 lymphoma, non-hodgkin, familial 10.6 KDM4C ICOSLG H2AC18 CSF3 CD8A CD4
320 leukemia, chronic lymphocytic 10.6 KDM4C ICOSLG H2AC18 CSF3 CD8A CD4
321 gastrointestinal tuberculosis 10.6 CD4 ALB
322 combined thymoma 10.6 CD8A CD4
323 bone marrow cancer 10.6 KDM4C ICOSLG H2AC18 CSF3 CD8A CD4
324 leukocyte disease 10.6 KDM4C ICOSLG H2AC18 CSF3 CD8A CD4
325 lipid storage disease 10.5 H2AC18 CCR6 ALB
326 skin melanoma 10.5 ICOSLG H2AC18 CCR6
327 hypotrichosis 1 10.5 PRDM10 KDM4C ICOSLG H2AC18 CD8A CD4
328 lung cancer susceptibility 3 10.5 PRDM10 KDM4C ICOSLG H2AC18 CD8A CCR6
329 autosomal genetic disease 10.5 PRDM10 KDM4C ICOSLG H2AC18 ERCC6 CD4
330 west nile encephalitis 10.5 CD8A CD4
331 hematologic cancer 10.5 KDM4C ICOSLG H2AC18 ERCC6 CSF3 CD8A
332 neuromuscular disease 10.5 PRDM10 ICOSLG H2AC18 ERCC6 CD8A CD4
333 body mass index quantitative trait locus 11 10.5 PRDM10 KDM4C ICOSLG H2AC18 CD4 CCR6
334 cone-rod dystrophy 2 10.5 PRDM10 ICOSLG CD8A CD4 ALB
335 neurosarcoidosis 10.5 CD8A CD4
336 myeloma, multiple 10.5 PRDM10 KDM4C ICOSLG H2AC18 CSF3 CD8A
337 muscular disease 10.5 PRDM10 KDM4C ICOSLG H2AC18 ERCC6 CD8A
338 eye disease 10.5 PRDM10 KDM4C ICOSLG H2AC18 ERCC6 CD8A
339 cd3zeta deficiency 10.5 CD8A CD4
340 autoimmune peripheral neuropathy 10.4 ICOSLG CD4
341 peripheral nervous system disease 10.4 PRDM10 ICOSLG H2AC18 ERCC6 CSF3 CD8A
342 immunodeficiency 18 10.4 CD8A CD4
343 leukemia, acute myeloid 10.4 PRDM10 LPP KDM4C ICOSLG H2AC18 ERCC6
344 hypotrichosis 11 10.3 LPAR6 LIPH
345 substance abuse 10.1 H2AC18 CD4 CCR6
346 alopecia areata 10.0
347 alopecia, androgenetic, 1 9.9
348 trichotillomania 9.9
349 hypertelorism 9.9
350 trichomegaly 9.9
351 retinitis pigmentosa 9.9
352 oliver-mcfarlane syndrome 9.9
353 familial isolated trichomegaly 9.9
354 neuroretinitis 9.9
355 ichthyosis 9.9
356 retinitis 9.9
357 central centrifugal cicatricial alopecia 9.9
358 pili torti 9.8
359 hypotonia 9.8
360 vitiligo-associated multiple autoimmune disease susceptibility 6 9.8
361 seborrheic dermatitis 9.8
362 lichen planus 9.8
363 mitochondrial complex iv deficiency 9.7
364 3-methylglutaconic aciduria, type iii 9.7
365 wilson disease 9.7
366 cerebellar degeneration 9.7
367 disorder of copper metabolism 9.7
368 pectus excavatum 9.7
369 polydactyly, postaxial, type a1 9.7
370 widow's peak 9.7
371 cranioectodermal dysplasia 1 9.7
372 trichohepatoenteric syndrome 1 9.7
373 hemochromatosis, neonatal 9.7
374 hemochromatosis, type 1 9.7
375 yemenite deaf-blind hypopigmentation syndrome 9.7
376 polydactyly 9.7
377 hypermethioninemia 9.7
378 meningocele 9.7
379 diarrhea 9.7
380 cholestasis 9.7
381 pituitary gland disease 9.7
382 night blindness 9.7
383 hypereosinophilic syndrome 9.7
384 mitochondrial disorders 9.7
385 whim syndrome 9.6
386 congenital heart defects, hamartomas of tongue, and polysyndactyly 9.6
387 bazex syndrome 9.6
388 erythema multiforme 9.6
389 dermatomyositis 9.6
390 charcot-marie-tooth disease 9.6
391 amenorrhea 9.6
392 hypothyroidism 9.6
393 urticaria 9.6
394 angioedema 9.6
395 dental caries 9.6
396 skin atrophy 9.6
397 lice infestation 9.6
398 scabies 9.6
399 localized scleroderma 9.6
400 molluscum contagiosum 9.6
401 tinea nigra 9.6
402 pemphigus 9.6
403 drug reaction with eosinophilia and systemic symptoms 9.6
404 linear scleroderma 9.6
405 stevens-johnson syndrome/toxic epidermal necrolysis 9.6
406 trichostasis spinulosa 9.6
407 rapidly involuting congenital hemangioma 9.6
408 erythema multiforme major 9.6
409 premature aging 9.6
410 pili gemini 9.6
411 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.6
412 neurofibromatosis, type ii 9.6
413 alopecia areata 1 9.6
414 bladder diverticulum 9.6
415 acrodermatitis enteropathica, zinc-deficiency type 9.6
416 argininosuccinic aciduria 9.6
417 ataxia-telangiectasia 9.6
418 leukoencephalopathy, hereditary diffuse, with spheroids 9.6
419 ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive 9.6
420 hypoascorbemia 9.6
421 melanosis, neurocutaneous 9.6
422 netherton syndrome 9.6
423 alopecia, congenital 9.6
424 ataxia and polyneuropathy, adult-onset 9.6
425 loose anagen hair syndrome 9.6
426 anxiety 9.6
427 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.6
428 alexithymia 9.6
429 diffuse alopecia areata 9.6
430 body dysmorphic disorder 9.6
431 leukodystrophy 9.6
432 hydronephrosis 9.6
433 protein-energy malnutrition 9.6
434 visual epilepsy 9.6
435 somatization disorder 9.6
436 ventricular septal defect 9.6
437 heart septal defect 9.6
438 ectodermal dysplasia 9.6
439 acrodermatitis 9.6
440 contact dermatitis 9.6
441 gingival overgrowth 9.6
442 tinea capitis 9.6
443 pustulosis of palm and sole 9.6
444 bartter disease 9.6
445 psoriasis 9.6
446 mitochondrial encephalomyopathy 9.6
447 dermatophytosis 9.6
448 enteropathica 9.6
449 frontal fibrosing alopecia 9.6
450 cerebral atrophy 9.6
451 encephalopathy 9.6
452 seizure disorder 9.6
453 discoid lupus erythematosus 9.6

Graphical network of the top 20 diseases related to Hair Disease:



Diseases related to Hair Disease
Sources

Symptoms & Phenotypes for Hair Disease

About this section

UMLS symptoms related to Hair Disease:


pruritus, exanthema

MGI Mouse Phenotypes related to Hair Disease:

45 (showing 1, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 integument MP:0010771 9.28 CD4 CD8A CSF3 DSG4 DSP ERCC3
Sources

Drugs & Therapeutics for Hair Disease

About this section

Drugs for Hair Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 41, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Minoxidil Approved, Investigational Phase 3 38304-91-5 4201
2 Antihypertensive Agents Phase 3
3 Pharmaceutical Solutions Phase 3
4 Vasodilator Agents Phase 3
5
Ornithine Approved, Nutraceutical Phase 2 70-26-8, 3184-13-2 6262
6 Anti-Infective Agents Phase 2
7 Antiparasitic Agents Phase 2
8 Antiprotozoal Agents Phase 2
9 Mitogens Phase 1, Phase 2
10 Immunosuppressive Agents Phase 1, Phase 2
11 Complement System Proteins Phase 1, Phase 2
12 Complement Inactivating Agents Phase 1, Phase 2
13 Immunologic Factors Phase 1, Phase 2
14 Complement Factor H Phase 1, Phase 2
15
Polidocanol Approved 9002-92-0
16
Edetic Acid Approved, Vet_approved 60-00-4, 62-33-9 6049
17
Petrolatum Approved, Investigational 8009-03-8
18
Pentetic acid Approved 67-43-6
19
Triamcinolone Approved, Vet_approved 124-94-7 31307
20
Ergocalciferol Approved, Nutraceutical 50-14-6 5280793
21
Vitamin D Approved, Nutraceutical, Vet_approved 1406-16-2
22
Calcium Approved, Nutraceutical 7440-70-2 271
23 Antibiotics, Antitubercular
24 Anti-Bacterial Agents
25 Hormone Antagonists
26 Anti-Inflammatory Agents
27 Triamcinolone diacetate
28 Emollients
29 triamcinolone acetonide
30 glucocorticoids
31 Sunscreening Agents
32 Triamcinolone hexacetonide
33 Micronutrients
34 Vitamins
35 Trace Elements
36 Nutrients
37 Ergocalciferols
38 Vitamin D2
39 Calcium, Dietary
40 Calciferol
41 Hormones

Interventional clinical trials:

(showing 13, show less)
# Name Status NCT ID Phase Drugs
1 Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial Unknown status NCT02999737 Phase 4
2 A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA Recruiting NCT04006457 Phase 3 PF-06651600
3 A PHASE 2B/3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF-06651600 IN ADULT AND ADOLESCENT ALOPECIA AREATA (AA) SUBJECTS WITH 50% OR GREATER SCALP HAIR LOSS Recruiting NCT03732807 Phase 2, Phase 3 PF-06651600 Induction Dose;PF-06651600 Maintenance Dose #1;PF-06651600 Maintenance Dose #2;PF-06651600 Maintenance Dose #3;Placebo
4 A Double-Blind, Randomized, Clinical Trial of the Efficacy and Safety Study to Compare Topical Herbal Solution and Minoxidil 5% in Healthy Male Subjects With Androgenetic Alopecia Active, not recruiting NCT03753113 Phase 3 Topical Minoxidil 5%
5 Phase II, Open-Label Study of the Effect of 15% Eflornithine Hydrochloride Cream on Facial Hair of Men of African-American Descent With Pseudofolliculitis Barbae: A Laser Scanning Confocal Microscopy and Video Imaging Study Completed NCT00176995 Phase 2 15% Eflornithine Hdyrochloride
6 Biocellular Regenerative Therapy in Hair Loss: Use of High Density Platelet-Rich Plasma Concentrates and Cell-Enriched Emulsified Adipose-Derived Tissue Stromal Vascular Fraction Recruiting NCT02849470 Phase 1, Phase 2
7 The Impact of a Pre-Shave Gel and Brush in Males With Pseudofolliculitis Barbae Completed NCT03043534
8 Point-of-Care Adipose-derived Cells for Hair Growth Completed NCT02729415
9 Clinical Safety and Efficacy of Prototype Devices for Hair Growth Control: Task 2.4 Completed NCT00402129
10 Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata Recruiting NCT04147845
11 The Analysis of Hair Count in Healthy Taiwanese Persons by Trichoscope Not yet recruiting NCT03937557
12 Role of Vitamin D in Androgenetic Alopecia Not yet recruiting NCT03154528
13 The Role of Dermoscopy in Diagnosis of Pigmentary Skin Lesions Not yet recruiting NCT03542539

Search NIH Clinical Center for Hair Disease

Cochrane evidence based reviews: hair diseases

Sources

Genetic Tests for Hair Disease

About this section
Sources

Anatomical Context for Hair Disease

About this section

The Foundational Model of Anatomy Ontology organs/tissues related to Hair Disease:

19
Hair

MalaCards organs/tissues related to Hair Disease:

40
Skin, Eye, T Cells, Bone, Brain, B Cells, Cortex
Sources

Publications for Hair Disease

About this section

Articles related to Hair Disease:

(showing 297, show less)
# Title Authors PMID Year
1
Tricho-hepatic-enteric syndrome (THES) without intractable diarrhoea. 42
30844479 2019
2
Pseudofolliculitis Barbae: A Review of Current Treatment Options 42
30909328 2019
3
Patient Perspectives: What is a pilomatricoma? 42
30675939 2019
4
Female Androgenetic Alopecia: An Update on Diagnosis and Management. 61
31677111 2020
5
'The psychosocial burden of alopecia areata and androgenetica': a cross-sectional multicentre study among dermatological out-patients in 13 European countries. 61
31465592 2020
6
Trachyonychia: a retrospective study of 122 patients in a period of 30 years. 61
31923322 2020
7
Longstanding patchy alopecia areata along the hairline, a variety of alopecia areata mimicking frontal fibrosing alopecia and other cases of hair loss. Case series of 11 patients. 61
31758714 2019
8
Magnetotrichography: Measuring the dc magnetic field produced by hair follicles. 61
31666670 2019
9
Alopecia Areata Incognita and Diffuse Alopecia Areata: Clinical, Trichoscopic, Histopathological, and Therapeutic Features of a 5-Year Study. 61
31723460 2019
10
Assessment of Treatment Efficacy of Diphenylcyclopropenone (DPCP) for Alopecia Areata. 61
31655499 2019
11
The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. 61
30806923 2019
12
Scalp bacterial shift in Alopecia areata. 61
30973913 2019
13
Mineralocorticoid Receptor Antagonists Stimulate Human Hair Growth ex vivo. 61
31522177 2019
14
Trichoscopy of Dark Scalp. 61
30643773 2018
15
Quantification of Hair Follicles in the Scalp in Mexican Mestizo Population. 61
30643777 2018
16
Study on Hair Distribution in Healthy Males for Hair Restoration Design. 61
30277939 2018
17
Frontal Fibrosing Alopecia Severity Index: A Trichoscopic Visual Scale That Correlates Thickness of Peripilar Casts with Severity of Inflammatory Changes at Pathology. 61
30410896 2018
18
Formulation and Evaluation of Licorice Shampoo in Comparison with Commercial Shampoo. 61
30568378 2018
19
In vitro determination of Mexican Mestizo hair shaft diameter using optical coherence tomography. 61
29171081 2018
20
Ex vivo confocal microscopy: an emerging technique in dermatology. 61
29785327 2018
21
Somatic sprouts of the Purkinje cells in a patient with multiple system atrophy. 61
29575082 2018
22
Hair and nail diseases in the mature patient. 61
29566920 2018
23
Spontaneous retroperitoneal hemorrhage in Menkes disease: A rare case report. 61
29419699 2018
24
Studies on the Proteome of Human Hair - Identification of Histones and Deamidated Keratins. 61
29371649 2018
25
Trichocyte Keratin-Associated Proteins (KAPs). 61
29797269 2018
26
Parietal scalp is another affected area in female pattern hair loss: an analysis of hair density and hair diameter. 61
29343978 2018
27
Novel mutations in the lipase H gene lead to secretion defects of LIPH in Chinese patients with autosomal recessive woolly hair/hypotrichosis (ARWH/HT). 61
29346610 2017
28
Syphilitic Alopecia: Case Reports and Trichoscopic Findings. 61
29177154 2017
29
Three Cases of Hair Loss Analyzed by the Point of View of the Analytical Psychology. 61
29118523 2017
30
Menkes disease: A rare disorder. 61
28955085 2017
31
Infundibular protein and RNA microarray analyses from affected and clinically non-affected scalp in male androgenetic alopecia patients. 61
28266729 2017
32
Assembling a Hand-Held Trichotillometer and Determination of Epilation Force in Normal Individuals. 61
28405550 2017
33
Induction of hair follicle dermal papilla cell properties in human induced pluripotent stem cell-derived multipotent LNGFR(+)THY-1(+) mesenchymal cells. 61
28220862 2017
34
Ataxia telangiectasia, Menkes kinky hair disease and neurocutaneous melanosis. 61
27002302 2017
35
[Psychological consequences of hair loss]. 61
28722460 2017
36
Mycological visits requested in a tertiary referral center: what can be hiding behind a suspected skin mycosis? 61
26484881 2016
37
Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia. 61
27151518 2016
38
The diagnostic value of trichoscopy in systemic sclerosis. 61
27900061 2016
39
Hair diseases: a big problem on a small surface. 61
27881935 2016
40
Reflectance Confocal Microscopy Algorithms for Inflammatory and Hair Diseases. 61
27692454 2016
41
Assessment of tissue levels of dickkopf-1 in androgenetic alopecia and alopecia areata. 61
26222765 2016
42
The trichotillometry: a technique for hair assessment. 61
25809589 2016
43
Differential Expression of Proteins Associated with the Hair Follicle Cycle - Proteomics and Bioinformatics Analyses. 61
26752403 2016
44
Menkes disease: what a multidisciplinary approach can do. 61
27574440 2016
45
Menkes Kinky Hair Disease. 61
26840692 2016
46
Experimental white piedra: a robust approach to ultrastructural analysis, scanning electron microscopy and etiological discoveries. 61
26476093 2016
47
Case Study: Somatic Sprouts and Halo-Like Amorphous Materials of the Purkinje Cells in Huntington's Disease. 61
25962893 2015
48
Increased apoptosis and hypomyelination in cerebral white matter of macular mutant mouse brain. 61
26937406 2015
49
Owner assessment of pruritus and gastrointestinal signs in apparently healthy dogs with no history of cutaneous or noncutaneous disease. 61
26178605 2015
50
Cyclosporine A increases hair follicle growth by suppressing apoptosis-inducing factor nuclear translocation: a new mechanism. 61
25619112 2015
51
Hair loss in children. 61
26370644 2015
52
Evaluation of hair loss. 61
26370640 2015
53
Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan. 61
26644955 2015
54
Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss. 61
26339482 2015
55
Molecular genetics of alopecias. 61
26370647 2015
56
North American Virginian Witch Hazel (Hamamelis virginiana): Based Scalp Care and Protection for Sensitive Scalp, Red Scalp, and Scalp Burn-Out. 61
25210333 2014
57
A case of trichotillomania with recently defined trichoscopic findings. 61
25191044 2014
58
The function of zebra stripes. 61
24691390 2014
59
Cerebellar expression of copper chaperone for superoxide, cytosolic cu/zn-superoxide dismutase, 4-hydroxy-2-nonenal, acrolein and heat shock protein 32 in patients with menkes kinky hair disease: immunohistochemical study. 61
25067875 2014
60
Selective hair therapy: bringing science to the fiction. 61
24387677 2014
61
Hair loss in infancy. 61
24566566 2014
62
Additional methods for diagnosing alopecia and appraising their severity. 61
24566569 2014
63
[Genetic hair diseases. An update]. 61
24177665 2013
64
Anti-wrinkle effect of bone morphogenetic protein receptor 1a-extracellular domain (BMPR1a-ECD). 61
24064062 2013
65
Hair cosmetics. 61
23974582 2013
66
The difficult hair loss patient: a particular challenge. 61
24574686 2013
67
Novel Frameshift Mutation in TRPS1 in a Ukrainian Patient with Trichorhinophalangeal Syndrome Type I. 61
24574699 2013
68
Dermoscopy for the pediatric dermatologist part I: dermoscopy of pediatric infectious and inflammatory skin lesions and hair disorders. 61
23405886 2013
69
A comparative study of hair shafts in scalp psoriasis and seborrheic dermatitis using atomic force microscopy. 61
22220807 2013
70
Psychotrichology: psychosomatic aspects of hair diseases. 61
23176605 2013
71
The importance of trichoscopy in clinical practice. 61
24170996 2013
72
Standardization of Shadbindu Taila: An Ayurvedic oil based medicine. 61
24049414 2013
73
Menkes kinky hair syndrome: a case report. 61
23217945 2012
74
Menkes syndrome presenting as possible child abuse. 61
23259200 2012
75
Prison dermatology: experience in the Texas Department of Criminal Justice dermatology clinic. 61
22899813 2012
76
Menkes kinky hair disease. 61
23112368 2012
77
Caspase-1 level is higher in the scalp in androgenetic alopecia. 61
22404322 2012
78
Qualitative investigation of fresh human scalp hair with full-field optical coherence tomography. 61
22502568 2012
79
Unveiling the roots of monogenic genodermatoses: genotrichoses as a paradigm. 61
22170492 2012
80
Differentiating inbred mouse strains from each other and those with single gene mutations using hair proteomics. 61
23251662 2012
81
Menkes kinky hair syndrome: a rare neurodegenerative disease. 61
22919529 2012
82
Videodermoscopy scalp psoriasis severity index (VSCAPSI): a useful tool for evaluation of scalp psoriasis. 61
21659071 2011
83
Hair care practices and scalp/hair disease in African American girls. 61
21571179 2011
84
Current standards in the diagnostics and therapy of hair diseases - hair consultation. 61
21284803 2011
85
Pathology, clinical features and treatments of congenital copper metabolic disorders--focus on neurologic aspects. 61
21112168 2011
86
Investigation of aging effects in human hair using atomic force microscopy. 61
20923464 2011
87
Biology of human hair: know your hair to control it. 61
21072698 2011
88
Gender aspects in skin diseases. 61
20384686 2010
89
Familial woolly hair disease. 61
20519796 2010
90
Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. 61
20302576 2010
91
Hair loss in elderly women. 61
20172841 2010
92
Cytokeratin 75 expression in central, centrifugal, cicatricial alopecia--new observations in normal and diseased hair follicles. 61
19614992 2010
93
Biology and genetics of hair. 61
20590427 2010
94
[Hair diseases]. 61
19957071 2009
95
Trichothiodystrophy and fragile hair: the distinction between diagnostic signs and diagnostic labels in childhood hair disease. 61
19754869 2009
96
Endocrine controls of keratin expression. 61
19274655 2009
97
Autosomal recessive woolly hair with hypotrichosis caused by a novel homozygous mutation in the P2RY5 gene. 61
18803659 2009
98
In vivo reflectance confocal microscopy: usefulness for diagnosing hair diseases. 61
21886715 2008
99
Menkes kinky hair disease: A case report. 61
18801184 2008
100
Pediatric skin disorders encountered in a dermatology outpatient clinic in Turkey. 61
18429805 2008
101
Advances in hair diseases. 61
19256313 2008
102
Transverse sectioning of the scalp (Headington technique) in the 19th century. 61
18096001 2008
103
E-dermatology: emails about dermatological diseases on the Internet. 61
17535402 2007
104
Hair follicle-specific keratins and their diseases. 61
17428470 2007
105
Case report of a Spanish patient with arrhythmogenic right ventricular cardiomyopathy and palmoplantar keratoderma without plakoglobin and desmoplakin gene modifications. 54
17045679 2007
106
Menkes syndrome presenting as myoclonic seizures: neuroimaging and EEG observations. 61
17621528 2007
107
Menkes kinky hair disease (Menkes syndrome). A case report. 61
17053847 2006
108
Antiandrogen therapy for skin and hair disease. 61
16677962 2006
109
Human hair keratin-associated proteins (KAPs). 61
16939781 2006
110
Autopsy case of acute encephalopathy linked to familial hemiplegic migraine with cerebellar atrophy and mental retardation. 61
16193840 2005
111
Psychological aspects of hair disease. 61
17166214 2005
112
Human hair abnormalities resulting from inherited desmosome gene mutations. 61
16077256 2005
113
Trichotemnomania: obsessive-compulsive habit of cutting or shaving the hair. 61
15627101 2005
114
Light and scanning electron microscopic examination of late changes in hair with hereditary trichodysplasia (Marie Unna hypotrichosis). 61
15573195 2004
115
[Alopecia areata and treatment]. 61
15516057 2004
116
[Psychological consequences of chronic hair diseases]. 61
15516058 2004
117
Differential diagnosis of hair loss in children. 61
16281597 2004
118
Effect of estrogen on plasma ceruloplasmin level in rats exposed to acute stress. 61
15122050 2004
119
[New and established methods for diagnosing hair diseases]. 61
12942183 2003
120
[Biology of the human hair follicle. New knowledge and the clinical significance]. 61
12942182 2003
121
[Genetically induced hair diseases]. 61
12942186 2003
122
[New and established methods in therapy of hair diseases]. 61
12942187 2003
123
Morphological approach to hair disorders. 61
12894995 2003
124
[Hair diseases in childhood]. 61
12090118 2002
125
[Visual field defect in a patient given sodium valporate then carbamazepine: possible effect of aminotransferase inhibition]. 61
11984493 2002
126
Hair and systemic disease. 61
11705356 2001
127
Scarring alopecia and the dermatopathologist. 61
11437938 2001
128
[Is alopecia areata a psychosomatic disease?]. 61
11270270 2001
129
[Hairdex: a tool for evaluation of disease-specific quality of life in patients with hair diseases]. 61
11284067 2001
130
Is kinky-hair disease a misnomer for Menkes syndrome? 61
11176670 2001
131
Mitochondrial encephalomyopathy with lactic acidosis and stroke like episodes (MELAS) with prominent degeneration of the intestinal wall and cactus-like cerebellar pathology. 61
11078225 2000
132
The human hair follicle immune system: cellular composition and immune privilege. 61
10809841 2000
133
Menkes kinky hair disease: an unusual case. 61
10872109 2000
134
Matting of hair: a multifactorial enigma. 61
11053910 2000
135
Hair diseases. 61
9769798 1998
136
A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. 54
9651581 1998
137
Hair today, gone tomorrow: transgenic mice with human repair deficient hair disease. 61
9657142 1998
138
[Symposium: Recent developments in pathogenesis and therapy of hair diseases 9 July 1997 in Munich]. 61
9565796 1998
139
[Rare hyperimmunoglobulinemia E syndromes]. 61
9775139 1998
140
Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles. 61
9588863 1998
141
A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix. 61
9402962 1997
142
Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. 61
9241275 1997
143
[Hair diseases: diagnosis and therapy]. 61
9289797 1997
144
Menkes' kinky hair disease associated with a large bladder diverticulum: a case report. 61
9255676 1997
145
Urologic abnormalities in Menkes' kinky hair disease: report of three cases. 61
9165480 1997
146
Topical liposome delivery of molecules to hair follicles in mice. 61
9039973 1997
147
Histochemistry of the human hair follicle. 61
8962490 1997
148
Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: a possible role for interleukin-1 and tumour necrosis factor-alpha in alopecia areata. 61
8977716 1996
149
Kinky hair disease with multiple eruption cysts: a case report. 61
8936518 1996
150
Menkes' Kinky Hair disease: new considerations. 61
9141833 1996
151
Hair keratinization in health and disease. 61
9238322 1996
152
Menkes' kinky-hair disease: radiologic findings in a patient treated with copper histidinate. 61
7704673 1995
153
[The morphological signs of hair disease in children poisoned by thallium and boron]. 61
7638883 1995
154
Cerebellar superoxide dismutase expression in Menkes' kinky hair disease: an immunohistochemical investigation. 61
7484097 1995
155
Does interleukin-1 induce hair loss? 61
8573920 1995
156
Nucleotide excision repair syndromes: molecular basis and clinical symptoms. 61
7746858 1995
157
[Menkes disease]. 61
7845659 1994
158
[Menkes' kinky hair disease: a clinical and pathological case report with special reference to glial changes in the brain damage]. 61
7826987 1994
159
Electrophysiological and 99mTc-HMPAO-SPECT studies in Menkes disease. 61
7943608 1994
160
Menkes kinky hair disease. 61
8028455 1994
161
Histochemical study of mitochondrial enzymes in cerebellar cortex of macular mutant mouse, a model of Menkes kinky hair disease. 61
8009964 1994
162
Copper distribution in fetus and placenta of the macular mutant mouse as a model of Menkes kinky hair disease. 61
7873696 1994
163
Cytokeratin expression in alopecia areata hair follicles. 61
7511864 1994
164
Effect of age and sex on copper-induced toxicity in the macular mutant mouse. An animal model for Menkes' kinky-hair disease. 61
7509170 1993
165
Cytochrome C oxidase deficiency and neuronal involvement in Menkes' kinky hair disease: immunohistochemical study. 61
8293191 1993
166
Evidence for a repair enzyme complex involving ERCC1 and complementing activities of ERCC4, ERCC11 and xeroderma pigmentosum group F. 61
8253091 1993
167
Menkes kinky hair disease: characteristic MR angiographic findings. 61
8237696 1993
168
Evidence for serum factors modulating antibody production in normal and macular mice. 61
8364504 1993
169
Intracellular distribution of hepatic copper in macular mutant mice. An animal model of Menkes' kinky-hair disease. 61
7688531 1993
170
Recovery of decreased antibody production by ceruloplasmin in the macular mutant mouse. 61
8488341 1993
171
Neuropathological study on cerebellum of macular mutant mouse heterozygote. 61
8310789 1993
172
The decreased immune responses in macular mouse, a model of Menkes' kinky hair disease. 61
8434133 1993
173
'Kinky hair' disease sheds light on copper metabolism. 61
8490649 1993
174
[New perspectives in hair research: in search of the "biological clock" of the hair cycle]. 61
1612914 1992
175
Urate oxidase activity and copper content in the liver of macular mutant mouse, a model animal for human congenital copper deficiency, Menkes' kinky hair disease. 61
1819648 1991
176
The effect of 1,25-dihydroxyvitamin D3 on the growth and differentiation of cultured human outer root sheath cells from normal subjects and patients with vitamin D-dependent rickets type II with alopecia. 61
1742246 1991
177
Disorders of the hair and scalp in children. 61
1870910 1991
178
Copper-induced toxicity in macular mutant mouse: an animal model for Menkes' kinky-hair disease. 61
1871775 1991
179
Movement disorder with abnormal copper metabolism--a case report and review of the literature. 61
1942656 1991
180
Correction of cerebrospinal fluid copper in Menkes kinky hair disease. 61
1930426 1991
181
[A case of Menkes' kinky hair disease with a renal calculus and diverticula of the bladder]. 61
1908921 1991
182
Metallothionein messenger RNA levels in the macular mutant mouse: an animal model of Menkes' kinky-hair disease. 61
1912099 1991
183
Menkes' kinky hair disease: morphological and immunohistochemical comparison of two autopsied patients. 61
2028748 1991
184
MR of progressive neurodegenerative change in treated Menkes' kinky hair disease. 61
2046911 1991
185
[What is new in genetically-induced hair diseases?]. 61
2087835 1990
186
[Menkes' kinky hair disease: report of 2 cases]. 61
2178069 1990
187
[A pathophysiological study of macular mutant mouse as a model of human Menkes kinky hair disease. I. Copper contents and copper dependent enzyme activities in various organs]. 61
2175632 1990
188
[A pathophysiological study of macular mutant mouse as a model of human Menkes kinky hair disease. II. Analysis of brain metabolism using 31P- and 1H-nuclear magnetic resonance spectroscopy]. 61
2261231 1990
189
D-penicillamine-induced copper deficiency in suckling mice: neurological abnormalities and brain mitochondrial enzyme activities. 61
2170057 1990
190
Electron microscopic study on the homozygote (Ml/Ml) of the macular mutant mouse. 61
2288383 1990
191
Cryosectioning of hair follicles. An improved method using liquid nitrogen conduction freezing. 61
1977260 1990
192
A comparative immunocytochemical study of human cerebellar cortex in X-chromosome-linked copper malabsorption (Menkes' kinky hair disease) and granule cell type cerebellar degeneration. 61
2511498 1989
193
Menkes' Disease (kinky Hair Disease). 61
28128144 1989
194
[Menkes' kinky hair disease: report of one case]. 61
2637598 1989
195
Cerebral MR of Menkes kinky-hair disease. 61
2492723 1989
196
Decreased blood flow and oxygen metabolism in the cerebellum, brain stem and thalamus in a case with Menkes kinky hair disease. 61
2618967 1989
197
Golgi study on the homozygote (Ml/Ml) of macular mutant mouse. 61
2473662 1989
198
Menkes kinky hair disease with 'ragged red' fibers. 61
3234609 1988
199
Atypical Menkes steely hair disease. 61
3189407 1988
200
Atypical form of Menkes kinky hair disease with mitochondrial NADH-CoQ reductase deficiency. 61
2452375 1988
201
Golgi study on macular mutant mouse after copper therapy. 61
2462325 1988
202
Catecholamine metabolism in kinky hair disease. 61
3233105 1988
203
Kinky hair disease: twenty five years later. 61
2839049 1988
204
[Hair disease or the effect of heat (fire)?]. 61
3407335 1988
205
Copper metabolism in the macular mutant mouse: an animal model of Menkes's kinky-hair disease. 61
3219371 1988
206
Biochemical study on the brain of the macular mutant mouse as a model of Menkes' kinky hair disease. 61
2453126 1988
207
Electron microscopic study on brain of macular mutant mouse after copper therapy. 61
3201920 1988
208
[Alopecia areata in children]. 61
3686512 1987
209
Diagnosis and management of the hair loss patient. 61
3652735 1987
210
Abnormal copper metabolism and regulation of metallothionein gene expression in Menkes' disease. 61
2959538 1987
211
Neuronal and vascular disorders of the brain and spinal cord in Menkes kinky hair disease. 61
3130871 1987
212
Clinico-pathological study on macular mutant mouse. 61
3564905 1987
213
Light and electron microscopic study on cerebellar cortex of macular mutant mouse as a model of Menkes kinky hair disease. 61
2821841 1987
214
Metallothionein in kidney and liver of the macular mouse as an animal model of Menkes' kinky hair disease. 61
3449862 1987
215
Golgi study on brain of macular mutant mouse as a model of Menkes kinky hair disease. 61
3577690 1987
216
Cerebral lipid and protein abnormalities in Menkes' steely-hair disease. 61
3599492 1986
217
Catecholamine metabolism in steely hair disease. 61
2941501 1986
218
[An autopsy case of Menkes' kinky hair disease--pathological and biochemical studies on the central nervous system]. 61
3707768 1986
219
Cerebellar changes of the female mice heterozygous for brindled gene. 61
3962601 1986
220
Menkes steely hair disease. 61
3721573 1986
221
[Menkes syndrome with excessive skeletal changes]. 61
2996077 1985
222
Thalamic lesions in a patient with Menkes kinky-hair disease. 61
4064386 1985
223
Menkes' kinky hair disease: clinical and experimental study. 61
4042823 1985
224
[Current trends in hair diseases]. 61
4049987 1985
225
Structural changes of hair after incorporation of the proline analogue L-azetidine-2-carboxylic acid. A model of hair disease by alteration of primary structure. 61
2408388 1985
226
Kinky hair disease with suspected pseudo-Bartter syndrome. 61
4061786 1985
227
Abnormalities of Purkinje cell arborization in brindled mouse cerebellum. A Golgi study. 61
4038413 1985
228
Neuropathologic study in the heterozygotes of X-linked brindled mutant mouse. 61
4050346 1985
229
[CT findings in Menkes' kinky hair disease]. 61
6712844 1984
230
Autoradiographic demonstration of the copper-accumulating tissues in mice with a defect homologous to Menkes' Kinky Hair disease. 61
6417634 1983
231
Cytochrome c oxidase deficiency in Menkes kinky hair disease. 61
6322607 1983
232
Menkes kinky hair disease: a search for closely linked restriction fragment length polymorphism. 61
6576980 1983
233
Copper-binding proteins in the liver and kidney from the patients with Menkes' kinky hair disease. 61
6836561 1983
234
[Menkes' kinky hair disease: report of a case]. 61
6821602 1983
235
Mitochondrial abnormalities in Menkes' kinky hair disease (MKHD). Electron-microscopic study of the brain from an autopsy case. 61
6868958 1983
236
Histochemical studies of fibroblasts from patients with Menkes kinky hair disease and Wilson's disease. 61
6290431 1982
237
A defect in catecholamine metabolism in kinky-hair disease. 61
7137961 1982
238
Prenatal and postnatal diagnosis of diseases of copper metabolism. 61
6753725 1982
239
[A syndrome: uncombable hair. Observation of 6 members of a family with pili canaliculi, associated with pili torti, progressive alopecia, atopic eczema and hamartomas]. 61
7107281 1982
240
[Neuropathological study of Menkes' kinky hair disease: on the mechanism of development of cerebrovascular lesions (author's transl)]. 61
7093069 1982
241
Menkes' kinky hair disease. I. Comparison of classical and unusual clinical and biochemical features in two patients. 61
7091567 1982
242
Menkes' kinky hair disease. 61
7187623 1982
243
Menkes' kinky hair disease. II. A clinicopathological report of three cases. 61
7091568 1982
244
Tissue copper concentrations of patients with Menke's kinky hair disease. 61
7211802 1981
245
Diagnosis of hair disease. 61
7232277 1980
246
[Trichopoliodystrophy or Menkes disease]. 61
7002275 1980
247
Polyamine metabolism in Menkes kinky hair disease. 61
6772349 1980
248
[Hair diseases in children]. 61
6249054 1980
249
Copper and neurological function. 61
6907087 1980
250
Distribution of ingested and injected radiocopper in two patients with Menkes' kinky hair disease. 61
514694 1979
251
Kinky hair disease. Biochemical, histochemical, and ultrastructural studies. 61
514687 1979
252
[Current knowledge of hair diseases. Part I. Hypertrichosis and hirsutism (author's transl)]. 61
519777 1979
253
Thalamic degeneration in X-chromosome--linked copper malabsorption. 61
443770 1979
254
Inducibility of metallothionein biosynthesis in cultured normal and Menkes kinky hair disease fibroblasts: effects of copper and cadmium. 61
471576 1979
255
[Autopsy case of Menkes kinky hair disease]. 61
439455 1979
256
Failure of human milk therapy in Menkes' kinky hair disease. 61
581719 1979
257
Kinky hair disease. Report of a case. 61
282544 1978
258
Menkes' syndrome (kinky hair disease) [proceedings]. 61
718236 1978
259
[Connective tissue diseases with cutaneous manifestation (author's transl)]. 61
754606 1978
260
Cell culture studies of Menkes kinky hair disease. 61
699339 1978
261
Metal-binding studies of metallothioneins in Menkes kinky hair disease. 61
699318 1978
262
An autopsy case of Menkes kinky hair disease. 61
716884 1978
263
Menkes' disease: neurophysiological aspects. 61
97372 1978
264
[Menkes' disease (new skin and hair ultrastructural abnormalities) (author's transl)]. 61
707942 1978
265
[Kinky hair disease (Menkes' syndrome)]. 61
691373 1978
266
Menkes kinky-hair disease. A report on its pathology. 61
654875 1978
267
New screening method for Wilson's disease and Menkes' kinky-hair disease. 61
73055 1977
268
Menkes' kinky (steely) hair disease. 61
588193 1977
269
Menkes' kinky hair disease. 61
865681 1977
270
[Menkes' kinky hair disease--2 cases]. 61
558778 1977
271
The peroxisomes of human hepatocytes. 61
190476 1977
272
Fine structure of the cerebellar cortex in Menkes Kinky-hair disease. X-chromosome-linked copper malabsorption. 61
831687 1977
273
Copper incorporation studies on cultured cells for prenatal diagnosis of Menkes' disease. 61
58201 1976
274
Inborn errors of copper metabolism: kinky hair disease and hepatolenticular degeneration. Therapeutic approaches. 61
979354 1976
275
Menkes' kinky hair disease: a light and electron microscopic study of the eye. 61
1245386 1976
276
Fine structural changes in the cerebellar cortex in kinky hair disease. 61
1028277 1976
277
[Dermatophyte and Candida genus fungal carrier state in piglets]. 61
1025841 1976
278
Kinky hair disease. Study of copper metabolism with use of 67Cu. 61
1180729 1975
279
[A patient with kinky hair disease (Menke's disease)]. 61
1168863 1975
280
Letter: Menkes' kinky hair disease treated with subcutaneous copper sulphate. 61
4140440 1974
281
Neuropathologic aspects in Menkes' Kinky hair disease (trichopoliodystrophy). Menkes' Kinky hair disease. 61
4140481 1974
282
Copper deficiency in the developing rat brain: a possible model for Menkes' steely-hair disease. 61
4368537 1974
283
Menkes kinky hair disease. A defect in metallothionein metabolism? 61
4458824 1974
284
Study of copper metabolism in kinky hair disease (Menkes' disease) and in hepatolenticular degeneration (Wilson's disease) utilizing 67Cu and radioactivity counting in the total body and various tissues. 61
4219083 1974
285
[Kinky hair disease--a new syndrome with cerebral degeneration]. 61
4588328 1973
286
Menkes' steely-hair (kinky-hair) disease. 61
4123446 1973
287
Menkes' kinky hair disease: further definition of the defect in copper transport. 61
4120259 1973
288
[Diagnosis and therapy of hair diseases. Trichography for the differential diagnosis of alopecia]. 61
4351593 1973
289
Kinky hair disease. 61
5045346 1972
290
[Diagnosis of hair diseases]. 61
5147906 1971
291
Mechanical properties of hairs from patients with different types of hair diseases. 61
5467267 1970
292
The ocular pathology of Menkes' disease. (Kinky hair disease). 61
5699324 1968
293
Argininosuccinic aciduria in hereditary hair diseases. 61
4185293 1968
294
Kinky hair disease. II. Biochemical studies. 61
5922551 1966
295
Kinky hair disease. I. Clinical and pathological features. 61
5922550 1966
296
[Rhodamin B in the diagnosis of hair diseases]. 61
14442552 1959
297
[Local thallium ointment therapy of mycotic hair disease of the skull; preliminary communication]. 61
14378319 1954
Sources

Variations for Hair Disease

About this section
Sources

Expression for Hair Disease

About this section
Search GEO for disease gene expression data for Hair Disease.
Sources

Pathways for Hair Disease

About this section

Pathways related to Hair Disease according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1
Innate Lymphoid Cell Differentiation Pathways 64
10.7 CD8A CD4 CCR6
Sources

GO Terms for Hair Disease

About this section

Cellular components related to Hair Disease according to GeneCards Suite gene sharing:

(showing 1, show less)
# Name GO ID Score Top Affiliating Genes
1 external side of plasma membrane GO:0009897 9.02 ICOSLG CD8A CD4 CCR6 ANTXR2

Biological processes related to Hair Disease according to GeneCards Suite gene sharing:

(showing 3, show less)
# Name GO ID Score Top Affiliating Genes
1 keratinization GO:0031424 9.46 KRT86 KRT81 DSP DSG4
2 T cell activation GO:0042110 9.13 ICOSLG CD8A CD4
3 cornification GO:0070268 8.92 KRT86 KRT81 DSP DSG4
Sources

Sources for Hair Disease

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....